Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 14, 2025 11:20 ET | Source: Research and Markets

PD-1 and PD-L1 Inhibitors Competitive Landscape 2025 Report: 180+ Companies, 200+ Drugs Analyzed

Dublin, May 14, 2025 (GLOBE NEWSWIRE) -- The "PD-1 and PD-L1 Inhibitors - Competitive landscape, 2025" has been added to ResearchAndMarkets.com's offering. The "PD-1 and PD-L1 Inhibitors -...
April 25, 2025 04:24 ET | Source: Research and Markets

Hedgehog Pathway Inhibitors Market Report 2025: Analysis and Forecast (2020-2030) by Generic Drug, Dosage, End User, Region and Company - Featuring BridgeBio Pharma, Eli Lilly, Roche & More

Dublin, April 25, 2025 (GLOBE NEWSWIRE) -- The "Hedgehog Pathway Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
April 21, 2025 06:49 ET | Source: Research and Markets

Gastric Neuroendocrine Tumors Market Report 2025 | Advancements in Diagnostics Propel Early Detection of gNETs

Dublin, April 21, 2025 (GLOBE NEWSWIRE) -- The "Gastric Neuroendocrine Tumors Market" report has been added to ResearchAndMarkets.com's offering. The gastric neuroendocrine tumor (gNET) market,...
April 10, 2025 09:50 ET | Source: Research and Markets

Epithelioma Treatment Market Forecast and Company Analysis Report 2025-2034: Amgen, AstraZeneca, BeiGene, BMS, F. Hoffmann-La Roche, J&J, Merck, Novartis, Pfizer, Regeneron, Sanofi, Sun Pharma

Dublin, April 10, 2025 (GLOBE NEWSWIRE) -- The "Epithelioma Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...
March 04, 2025 07:34 ET | Source: Research and Markets

AXL Inhibitors Pipeline Research Report 2025: Features Insights on 16+ Companies and 20+ Pipeline Drugs, Including Cabozantinib (Exelixis/Ipsen), BA 3011 (BioAtla) & TP-0903 (Sumitomo Dainippon Pharma Oncology)

Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "AXL Inhibitors - Pipeline Insight, 2025" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
December 31, 2024 04:01 ET | Source: Research and Markets

Oncology Pharmaceuticals Market Research 2024-2029, Profiles of Major Players - Bristol-Myers Squibb, Merck & Co, F. Hoffmann-La Roche, Johnson & Johnson, and AstraZeneca

Dublin, Dec. 31, 2024 (GLOBE NEWSWIRE) -- The "Oncology Pharmaceuticals Market" report has been added to ResearchAndMarkets.com's offering.The global market for oncology pharmaceuticals was valued...
December 23, 2024 11:35 ET | Source: Research and Markets

Gynecological Cancer Drugs Research Report 2024: Personalized Medicine Revolutionizes Gynecological Cancer Care with Targeted Therapies - Explore Potential $24 Billion Opportunities by 2030

Dublin, Dec. 23, 2024 (GLOBE NEWSWIRE) -- The "Gynecological Cancer Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
December 18, 2024 05:49 ET | Source: Research and Markets

Urothelial Cancer Drugs Markets and Competitive Landscape Analysis, 2024-2030, Featuring Profiles of 42 Major Companies, Including AstraZeneca, Bristol-Myers Squibb, Celgene Corporation, and Eli Lilly & Co

Dublin, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The "Urothelial Cancer Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
December 03, 2024 05:53 ET | Source: Research and Markets

Head and Neck Cancer Therapeutics Market Research Report 2024-2030: Technological Integration of AI and Precision Medicine in Cancer Therapeutics Enhances Growth

Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "Head and Neck Cancer Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
September 11, 2024 11:54 ET | Source: Research and Markets

India Liver Cancer Therapeutics Research Report 2024-2030 Featuring Natco Pharma, Dr. Reddy's Laboratories, Intas Pharmaceuticals, Mylan Pharmaceuticals, Lupin, Biocon, and Hetero Labs

Dublin, Sept. 11, 2024 (GLOBE NEWSWIRE) -- The "India Liver Cancer Therapeutics Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" report has been added to ...

Next Page keyboard_arrow_right